Literature DB >> 4816312

I.C.I. 46,474 in breast cancer.

M J O'Halloran, P G Maddock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4816312

Source DB:  PubMed          Journal:  J Ir Med Assoc        ISSN： 0021-129X


× No keyword cloud information.
  5 in total

1.  Tamoxifen in the management of metastatic cancer of the breast.

Authors:  L A Cone; N E Romanoff; N A Helm
Journal:  West J Med       Date:  1979-09

Review 2.  Long-term adjuvant tamoxifen therapy for breast cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

3.  The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

Review 4.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 5.  Gynaecologic effects of tamoxifen.

Authors:  D Y Kuo; C D Runowicz
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.